Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19

被引:42
|
作者
Baptista, Abrahao Fontes [1 ,2 ,3 ,4 ]
Baltar, Adriana [2 ,5 ]
Okano, Alexandre Hideki [1 ,2 ,3 ,6 ]
Moreira, Alexandre [7 ]
Campos, Ana Carolina Pinheiro [8 ]
Fernandes, Ana Mercia [9 ]
Brunoni, Andre Russowsky [10 ,11 ]
Badran, Bashar W. [12 ]
Tanaka, Clarice [2 ,13 ]
de Andrade, Daniel Ciampi [2 ,9 ]
da Silva Machado, Daniel Gomes [14 ]
Morya, Edgard [15 ]
Trujillo, Eduardo [1 ,2 ]
Swami, Jaiti K. [16 ]
Camprodon, Joan A. [17 ,18 ]
Monte-Silva, Katia [2 ,19 ]
Sa, Katia Nunes [2 ,20 ,21 ]
Nunes, Isadora [21 ]
Goulardins, Juliana Barbosa [2 ,4 ,7 ,22 ]
Bikson, Marom [16 ]
Sudbrack-Oliveira, Pedro [23 ]
de Carvalho, Priscila [13 ]
Duarte-Moreira, Rafael Jardim [1 ,2 ]
Pagano, Rosana Lima [8 ]
Shinjo, Samuel Katsuyuki [24 ]
Zana, Yossi [1 ]
机构
[1] Fed Univ ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo, Brazil
[2] NAPeN Network Rede Nucleos Assistencia & Pesquisa, Sao Bernardo Do Campo, Brazil
[3] Univ Estadual Campinas, Brazilian Inst Neurosci & Neurotechnol, Ctr Pesquisa Invest & Difusao, Fundacao Amparo Pesquisa Estado Sao Paulo BRAINN, Campinas, Brazil
[4] Univ Sao Paulo, Lab Med Invest 54 LIM 54, Sao Paulo, Brazil
[5] Specialized Neuromodulat Ctr Neuromod, Recife, PE, Brazil
[6] Univ Estadual Londrina, Grad Program Phys Educ, Londrina, Parana, Brazil
[7] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
[8] Hosp Sirio Libanes, Lab Neurosci, Sao Paulo, Brazil
[9] Univ Sao Paulo, Fac Med FMUSP, Dept Neurol, Ctr Dor,LIM62, Sao Paulo, Brazil
[10] Inst Nacl Biomarcadores Neuropsiquiatria, Lab Neurociencias LIM 27, Serv Interdisciplinar Neuromodulacao, Sao Paulo, Brazil
[11] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Psiquiatria, Sao Paulo, Brazil
[12] Med Univ South Carolina, Dept Psychiat, Charleston, SC 29425 USA
[13] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Cent, Sao Paulo, Brazil
[14] Univ Fed Rio Grande do Norte, Grad Program Collect Hlth, Natal, RN, Brazil
[15] Santos Dumont Inst, Edmond & Lily Safra Int Neurosci Inst, Macaiba, Brazil
[16] CUNY, City Coll New York, Dept Biomed Engn, New York, NY 10031 USA
[17] Massachusetts Gen Hosp, Lab Neuropsychiat & Neuromodulat, Boston, MA 02114 USA
[18] Harvard Med Sch, Boston, MA 02115 USA
[19] Univ Fed Pernambuco, Appl Neurosci Lab, Recife, PE, Brazil
[20] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil
[21] Pontificia Univ Catolica Minas Gerais, Dept Physiotherapy, Betim, Brazil
[22] Univ Cruzeiro Sul UNICSUL, Sao Paulo, Brazil
[23] Univ Sao Paulo, Fac Med FMUSP, Sao Paulo, Brazil
[24] Univ Sao Paulo, Fac Med FMUSP, Div Rheumatol, Sao Paulo, Brazil
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
基金
美国国家卫生研究院; 巴西圣保罗研究基金会;
关键词
coronavirus; COVID-19; non-invasive vagus nerve stimulation; taVNS; tDCS; TMS; neuromodulation; NIBS; DIRECT-CURRENT STIMULATION; VAGUS NERVE-STIMULATION; ACUTE RESPIRATORY SYNDROME; HEART-RATE-VARIABILITY; TRANSCRANIAL MAGNETIC STIMULATION; SYNDROME CORONAVIRUS INFECTION; NEURAL CELL-LINES; IMMUNE-SYSTEM; INFLAMMATORY MARKERS; PERSISTENT INFECTION;
D O I
10.3389/fneur.2020.573718
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Novel coronavirus disease (COVID-19) morbidity is not restricted to the respiratory system, but also affects the nervous system. Non-invasive neuromodulation may be useful in the treatment of the disorders associated with COVID-19. Objective: To describe the rationale and empirical basis of the use of non-invasive neuromodulation in the management of patients with COVID-10 and related disorders. Methods: We summarize COVID-19 pathophysiology with emphasis of direct neuroinvasiveness, neuroimmune response and inflammation, autonomic balance and neurological, musculoskeletal and neuropsychiatric sequela. This supports the development of a framework for advancing applications of non-invasive neuromodulation in the management COVID-19 and related disorders. Results: Non-invasive neuromodulation may manage disorders associated with COVID-19 through four pathways: (1) Direct infection mitigation through the stimulation of regions involved in the regulation of systemic anti-inflammatory responses and/or autonomic responses and prevention of neuroinflammation and recovery of respiration; (2) Amelioration of COVID-19 symptoms of musculoskeletal pain and systemic fatigue; (3) Augmenting cognitive and physical rehabilitation following critical illness; and (4) Treating outbreak-related mental distress including neurological and psychiatric disorders exacerbated by surrounding psychosocial stressors related to COVID-19. The selection of the appropriate techniques will depend on the identified target treatment pathway. Conclusion: COVID-19 infection results in a myriad of acute and chronic symptoms, both directly associated with respiratory distress (e.g., rehabilitation) or of yet-to-be-determined etiology (e.g., fatigue). Non-invasive neuromodulation is a toolbox of techniques that based on targeted pathways and empirical evidence (largely in non-COVID-19 patients) can be investigated in the management of patients with COVID-19.
引用
收藏
页数:18
相关论文
empty
未找到相关数据